These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10954144)

  • 1. Illicit drug injectors' strategies for cleaning needles and syringes: findings from qualitative research.
    Hughes R
    Scand J Public Health; 2000 Jun; 28(2):158-60. PubMed ID: 10954144
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug injectors and the cleaning of needles and syringes.
    Hughes RA
    Eur Addict Res; 2000 Mar; 6(1):20-30. PubMed ID: 10729739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention.
    Koester S; Glanz J; Barón A
    AIDS Behav; 2005 Mar; 9(1):27-39. PubMed ID: 15812611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addiction treatment: promoting a medical approach to substance use.
    Stein GL; Fleischman AR
    J Urban Health; 1998 Sep; 75(3):558-83. PubMed ID: 9762650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syringe type and drug injector risk for HIV infection: a case study in Texas.
    Zule WA; Desmond DP; Neff JA
    Soc Sci Med; 2002 Oct; 55(7):1103-13. PubMed ID: 12365524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hygiene and uncertainty in qualitative accounts of hepatitis C transmission among drug injectors in Serbia.
    Rhodes T; Zikic B; Prodanović A; Kuneski E; Bernays S
    Soc Sci Med; 2008 Mar; 66(6):1437-47. PubMed ID: 18201809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.
    Estrada AL
    Public Health Rep; 2002; 117 Suppl 1(Suppl 1):S126-34. PubMed ID: 12435836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty.
    Rhodes T; Davis M; Judd A
    Addiction; 2004 May; 99(5):621-33. PubMed ID: 15078237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Knowledge about hepatitis B and C viruses and HIV among blood donors in Casablanca].
    Boutayeb H; Aamoum A; Benchemsi N
    East Mediterr Health J; 2006 Sep; 12(5):538-47. PubMed ID: 17333791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once more unto the breach: controlling hepatitis C in injecting drug users.
    Wodak A; Crofts N
    Addiction; 1996 Feb; 91(2):181-4. PubMed ID: 8835275
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen].
    Fuglsang T; Fouchard JR; Ege PP
    Ugeskr Laeger; 2000 Jul; 162(27):3860-4. PubMed ID: 10920701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour.
    Rhodes T; Hunter GM; Stimson GV; Donoghoe MC; Noble A; Parry J; Chalmers C
    Addiction; 1996 Oct; 91(10):1457-67. PubMed ID: 8917914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk behaviours of young Indo-Chinese injecting drug users in Sydney and Melbourne.
    Maher L; Sargent P; Higgs P; Crofts N; Kelsall J; Le TT
    Aust N Z J Public Health; 2001; 25(1):50-4. PubMed ID: 11297303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oregon's exclusion of syringes from its 1987 drug paraphernalia law was an HIV prevention measure.
    Wright LN; Gebbie KM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S144-5. PubMed ID: 9663641
    [No Abstract]   [Full Text] [Related]  

  • 16. [Widespread risk behavior among injecting drug users. Over 80 percent HCV-infected--7 percent have HIV, as demonstrated by the first baseline study].
    Hillgren K; Sarkar K; Elofsson S; Britton S
    Lakartidningen; 2012 Jun 19-26; 109(25):1221-5. PubMed ID: 22838111
    [No Abstract]   [Full Text] [Related]  

  • 17. Qualitative accounts of needle and syringe cleaning techniques among people who inject drugs in Sydney, Australia.
    Nathani J; Iversen J; Shying K; Byrne J; Maher L
    Drug Alcohol Rev; 2010 Jul; 29(4):413-9. PubMed ID: 20636658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk and blood-borne virus testing among men who inject image and performance enhancing drugs, Sydney, Australia.
    Rowe R; Berger I; Yaseen B; Copeland J
    Drug Alcohol Rev; 2017 Sep; 36(5):658-666. PubMed ID: 28244160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis C, HIV, and risk behaviors for blood-borne infections: a population-based survey of the adult population of T'bilisi, Republic of Georgia.
    Stvilia K; Tsertsvadze T; Sharvadze L; Aladashvili M; del Rio C; Kuniholm MH; Nelson KE
    J Urban Health; 2006 Mar; 83(2):289-98. PubMed ID: 16736377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV revisited: preventing the spread of blood-borne viruses among injecting drug users.
    Wodak A; Crofts N
    Aust J Public Health; 1994 Sep; 18(3):239-41. PubMed ID: 7841248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.